We help our clients in the healthcare industries
build value for their products using four essential steps
PHMR Market Access Alerts
Your personal watchdog on the fast-moving pharmaceutical world
Our market access alerts are hand-picked items of breaking industry news. You can become a subscriber for free and receive these alerts direct to your inbox.
Our industry specific knowledge of the field allows us sort through the mass of worldwide news and go straight to the items which will affect you.
Our latest alerts direct to your inbox.
Just enter your email address below and we'll make sure you never miss out on a market access alert again.
Alternatively you can unsubscribe here.
- 22 Jun 2015 PHMR presents poster on PFS2 at HTAi Oslo and ABPI welcomes focus on medicines optimisation in recent DoH report
- 18 May 2015 WHO release latest World Health Statistics and SMC recommends Takeda’s Entyvio for ulcerative colitis
- 11 May 2015 ABPI study shows clinical trial disclosure rate improves and EMA updates rules on declarations of interests
- 1 May 2015 King’s Fund report reveals NHS performance and 11 new medicines receive CHMP recommendation for EU approval
- 24 Apr 2015 Novartis’ heart failure medicine takes first step towards early access and EMA scientific advice leads to stronger applications
- 17 Apr 2015 WHO calls for disclosure of previously unreported clinical trials, and NIHR Horizon Scanning Centre’s latest briefings on cancer
- 10 Apr 2015 NICE and the general election, England’s Health Life Expectancy, and survey reveals public support to raise taxes to fund NHS
- 27 Mar 2015 UK cancer survival rates, latest NICE guidance and two reports show NICE slows market access for cancer drugs
- 20 Mar 2015 3 medicines remain in the Cancer Drug Fund and Australian Pharma calls to fast track oncology drugs
- 13 Mar 2015 Skin cancer drug first in early access scheme, SMC issues latest recommendations and NHS selects 29 sites for new models of care